SCHEMBL6986233

SCHEMBL6986233

O=C(O)NC(=S)Nc1ccc(C(=O)NNS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.62
KMT2A Q03164 2/20 0.62
MEN1 O00255 1/20 0.62
GAA P10253 5/20 0.62
ALDH1A1 P00352 5/20 0.62
TDP1 Q9NUW8 2/20 0.62
GPR55 Q9Y2T6 4/20 0.57
KDM4E B2RXH2 1/20 0.56
HPGD P15428 3/20 0.55
HTT P42858 1/20 0.55
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
PLK1 P53350 1/20 0.54
CA9 Q16790 1/20 0.54
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
ALOX12 P18054 1/20 0.54
CYP2C19 P33261 1/20 0.54
RECQL P46063 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979280 0.86 KAT6A (0.73) KAT6AKMT2AMEN1GAAALDH1A1
SCHEMBL4765513 0.79 KAT6A (1.00) KAT6AKMT2AMEN1GAAHTT
SCHEMBL27460744 0.77 KAT6A (0.68) KAT6AKMT2AMEN1GAAALDH1A1
SCHEMBL26104327 0.77 MEN1 (1.00) KAT6AKMT2AMEN1GAAHTT
SCHEMBL3072716 0.77 ALDH1A1 (0.80) KAT6AKMT2AMEN1GAAALDH1A1
SCHEMBL7950479 0.76 KAT6A (0.54) KAT6AKMT2AMEN1GAAALDH1A1
SCHEMBL6400145 0.76 KAT6A (0.81) KAT6AKMT2AMEN1GAAHTT
SCHEMBL17066647 0.75 GPR55 (0.82) KMT2AMEN1GAAALDH1A1GPR55
SCHEMBL7234905 0.75 KAT6A (0.61) KAT6AKMT2AMEN1GAAKDM4E
SCHEMBL20233293 0.75 KAT6A (0.78) KAT6AKMT2AMEN1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596749-B2 Neuropeptide y receptor ligand LES LABORATOIRES SERVIER (FR) 2003-07-22 US disclosed
EP-1044970-B1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-01-15 EP disclosed
US-20010018522-A1 Aminotriazole compounds LES LABORATOIRES SERVIER (FR) 2001-08-30 US disclosed
EP-1044970-A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 2000-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018522-A1 Aminotriazole compounds NPY1R, NPY2R, NPY4R KAT6A 1340/4885KMT2A 816/4885MEN1 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.